Solventum Corporation ( SOLV) - Key Metrics
SOLV Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $11.48 | $0.36 | $0.55 | $0.18 |
| 2025Q3 | $12.03 | $7.26 | $0.44 | -$0.12 |
| 2025Q2 | $12.41 | $0.52 | $0.97 | $0.34 |
| 2025Q1 | $11.92 | $0.79 | $0.17 | -$0.46 |
SOLV Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 54.74 |
| 2025Q3 | ? | 2.51 |
| 2025Q2 | ? | 36.68 |
| 2025Q1 | ? | 24.10 |
SOLV
Price: $80.98
52 week price:
Earnings Per Share: 8.17 USD
P/E Ratio: 9.59
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United Kingdom
Market Capitalization: 13.6 billion